Bessemer Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29K Sell
493
-2,604
-84% -$109K ﹤0.01% 1872
2026
Q1
$100K Sell
3,097
-16,101
-84% -$596K ﹤0.01% 1519
2025
Q4
$808K Sell
19,198
-1,382
-7% -$55.7K ﹤0.01% 1013
2025
Q3
$706K Buy
+20,580
New +$590K ﹤0.01% 744
2025
Q2
Sell
-55
Closed -$2K 2643
2025
Q1
$2K Sell
55
-12,570
-100% -$479K ﹤0.01% 2282
2024
Q4
$500K Sell
12,625
-25,400
-67% -$962K ﹤0.01% 881
2024
Q3
$1.29M Sell
38,025
-5,101
-12% -$144K ﹤0.01% 731
2024
Q2
$935K Buy
43,126
+7,376
+21% +$155K ﹤0.01% 672
2024
Q1
$793K Buy
35,750
+6,940
+24% +$169K ﹤0.01% 708
2023
Q4
$793K Buy
28,810
+6,010
+26% +$145K ﹤0.01% 709
2023
Q3
$509K Buy
22,800
+12,510
+122% +$322K ﹤0.01% 787
2023
Q2
$262K Buy
+10,290
New +$249K ﹤0.01% 971
2023
Q1
Sell
-188
Closed -$4K 2079
2022
Q4
$4K Buy
+188
New +$4.37K ﹤0.01% 1688
2021
Q4
Sell
-82
Closed -$4K 1984
2021
Q3
$4K Buy
+82
New +$3.58K ﹤0.01% 1556

Other funds holding VCYT

Bessemer Group's VCYT Position: Q2 2026 in Review

Bessemer Group reduced its Veracyte (VCYT) stake by 84% in Q2 2026, selling an estimated $109K and leaving 493 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Bessemer Group first reported a position in VCYT in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.29M in Q3 2024. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bessemer Group held 493 shares of Veracyte worth $29K as of Q2 2026.
  • Bessemer Group sold 2,604 Veracyte shares in Q2 2026, an estimated $109K.
  • Veracyte made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1872 holding.
  • Bessemer Group first reported a position in Veracyte in Q3 2021 and has held it in 14 quarters since.
  • Bessemer Group's Veracyte position peaked at $1.29M in Q3 2024.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.